EA200500065A1 - Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ - Google Patents

Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ

Info

Publication number
EA200500065A1
EA200500065A1 EA200500065A EA200500065A EA200500065A1 EA 200500065 A1 EA200500065 A1 EA 200500065A1 EA 200500065 A EA200500065 A EA 200500065A EA 200500065 A EA200500065 A EA 200500065A EA 200500065 A1 EA200500065 A1 EA 200500065A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
stationary
blood clot
fibrinolytic metalloproteinase
vascular access
Prior art date
Application number
EA200500065A
Other languages
English (en)
Other versions
EA007654B1 (ru
Inventor
Кристофер Ф. Тумбс
Original Assignee
Эмджен, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/466,276 external-priority patent/US6455269B1/en
Priority claimed from US10/177,916 external-priority patent/US7033776B2/en
Application filed by Эмджен, Инк. filed Critical Эмджен, Инк.
Publication of EA200500065A1 publication Critical patent/EA200500065A1/ru
Publication of EA007654B1 publication Critical patent/EA007654B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/044—Proteins; Polypeptides; Degradation products thereof
    • A61L29/048—Other specific proteins or polypeptides not covered by A61L29/045 - A61L29/047
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Предоставляется способ для локализованного внутрисосудистого введения фибринолитической металлопротеиназы субъекту-человеку в количествах, безопасных и эффективных в плане лизиса закупоривающего, содержащего фибрин кровяного сгустка, при этом также позволяющих избежать нейтрализующих эффектов альфа-2-макроглобулина в циркулирующей крови. Также предоставляется способ лечения кровяного сгустка внутри или вокруг стационарного устройства сосудистого доступа или прикрепленного к нему кровяного сгустка. Также предоставляется способ восстановления раскрытия и функции стационарного устройства сосудистого доступа.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500065A 1999-12-17 2003-06-23 Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ EA007654B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/466,276 US6455269B1 (en) 1999-12-17 1999-12-17 Method for localized administration of fibrinolytic metalloproteinases
US10/177,916 US7033776B2 (en) 1999-12-17 2002-06-21 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
PCT/US2003/019702 WO2004000348A1 (en) 2002-06-21 2003-06-23 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases

Publications (2)

Publication Number Publication Date
EA200500065A1 true EA200500065A1 (ru) 2005-08-25
EA007654B1 EA007654B1 (ru) 2006-12-29

Family

ID=35757635

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500065A EA007654B1 (ru) 1999-12-17 2003-06-23 Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ

Country Status (2)

Country Link
EA (1) EA007654B1 (ru)
RS (1) RS20050031A (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2662145C2 (ru) * 2017-01-23 2018-07-23 Ильдар Наилевич Нурмеев Способ профилактики тромбоза у пациентов с центральным венозным катетером

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830468A (en) * 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase

Also Published As

Publication number Publication date
RS20050031A (en) 2007-06-04
EA007654B1 (ru) 2006-12-29

Similar Documents

Publication Publication Date Title
NO20050328L (no) Fremgangsmate for behandling av okklusjon av intravenost kateter ved anvendelse av fibrinolytiske metalloproteinaser
Belcaro et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study
ATE355852T1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE281839T1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
DE68914199D1 (de) Schutzeinrichtung gegen gesundheitliche Schädigung des Blutes, besonders Thrombosen, Embolien, Gefässpasmen, Hämorrhagien, Hämopathien und das Vorhandensein von anormalen Elementen im Blut.
ATE555782T1 (de) Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz
EA200100925A1 (ru) Применение глицинбетаина в качестве антитромботического средства
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE60021111D1 (de) Verwendung von fibrinolytischen metallproteinasen zur behandlung von blutgerinseln
EA200500065A1 (ru) Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ
TR200501763T2 (tr) Tedavi ve ilaç tarama yöntemleri
ATE498305T1 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
GB2333964B (en) Intravenous coagulation catheter for treatment of varicose veins
CA2109736A1 (en) Medical appliance
RU96101499A (ru) Способ лечения тромбоза воротной вены
RU2222264C2 (ru) Способ лечения трофических язв венозной этиологии
RU98107980A (ru) Способ хирургического лечения ишемической болезни сердца
RU93029226A (ru) Способ лечения атопического дерматита
RU2001132695A (ru) Способ лечения поздних лучевых повреждений кожи и подкожной клетчатки
RU98102868A (ru) Способ лечения больных острым флеботромбозом
RU94005985A (ru) Способ лечения алопеции
RU95104410A (ru) Способ эндовазальной аутовенозной окклюзии вен нижних конечностей
RU93042070A (ru) Способ диагностики посттравматических тромбозов глубоких вен при переломах костей голени

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ RU